Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.04 is 35% above its 5-year average of -1.60, near the high end of its 5-year range (-2.04–-1.04).
37.16% above its 12-month average of -1.66.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.27.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.04
EARNINGS PER SHARE (EPS) AVG TTM
-1.66
EARNINGS PER SHARE (EPS) AVG 3Y
-1.77
EARNINGS PER SHARE (EPS) AVG 5Y
-1.60
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+37.16%
CURRENT VS 3Y AVG
+41.08%
CURRENT VS 5Y AVG
+34.93%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Immuneering Corporation
Market Cap
$143.39M
Earnings Per Share (EPS)
-1.04
TTM Avg
-1.66
3Y Avg
-1.77
5Y Avg
-1.60
Market Cap
$144.65M
Earnings Per Share (EPS)
-12.04
TTM Avg
-8.05
3Y Avg
-55.02
5Y Avg
-123.25
Market Cap
$146.58M
Earnings Per Share (EPS)
-1.64
TTM Avg
-1.85
3Y Avg
-1.46
5Y Avg
-1.46
Market Cap
$140.10M
Earnings Per Share (EPS)
-2.52
TTM Avg
-2.32
3Y Avg
-1.91
5Y Avg
-1.63
Market Cap
$146.71M
Earnings Per Share (EPS)
-0.61
TTM Avg
-0.35
3Y Avg
-0.32
5Y Avg
-0.30
Market Cap
$147.97M
Earnings Per Share (EPS)
-0.51
TTM Avg
-0.38
3Y Avg
-0.76
5Y Avg
-1.59
Market Cap
$138.69M
Earnings Per Share (EPS)
-1.11
TTM Avg
-1.59
3Y Avg
-2.87
5Y Avg
-3.93
Market Cap
$139.33M
Earnings Per Share (EPS)
-0.18
TTM Avg
-0.17
3Y Avg
-0.17
5Y Avg
-0.09
Market Cap
$137.77M
Earnings Per Share (EPS)
2.68
TTM Avg
-1.38
3Y Avg
-6.44
5Y Avg
-7.90
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immuneering Corporation (IMRX) | $143.39M | -1.04 | -1.66 | -1.77 | -1.60 |
| Korsana Biosciences, Inc. (KRSA)vs › | $144.65M | -12.04 | -8.05 | -55.02 | -123.25 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.58M | -1.64 | -1.85 | -1.46 | -1.46 |
| Nyxoah S.A. (NYXH)vs › | $140.10M | -2.52 | -2.32 | -1.91 | -1.63 |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $146.71M | -0.61 | -0.35 | -0.32 | -0.30 |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | -0.51 | -0.38 | -0.76 | -1.59 |
| Alpha Cognition Inc (ACOG)vs › | $138.69M | -1.11 | -1.59 | -2.87 | -3.93 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $139.33M | -0.18 | -0.17 | -0.17 | -0.09 |
| Fortress Biotech, Inc. (FBIOP)vs › | $137.77M | 2.68 | -1.38 | -6.44 | -7.90 |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.51M | -0.04 | -0.09 | -0.17 | -0.13 |
Trailing EPS (TTM)
$-1.04
Forward EPS (Est.)
$-1.12
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.27 |
| 2024-12-31 | -2.04 |
| 2023-12-31 | -1.88 |
| 2022-12-31 | -1.87 |
| 2021-12-31 | -1.27 |
| 2020-12-31 | -1.26 |
| 2019-12-31 | -0.60 |
